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Accepted 6 October; published on WWW 12 November 1998During hair growth, cortical cells emerging from the
proliferative follicle bulb rapidly undergo a differentiation
program and synthesise large amounts of hair keratin
proteins. To identify some of the controls that specify
expression of hair genes we have defined the minimal
promoter of the wool keratin intermediate filament gene
K2.10. The region of this gene spanning nucleotides - 350 to
+53 was sufficient to direct expression of the lacZ gene to
the follicle cortex of transgenic mice but deletion of
nucleotides - 350 to - 150 led to a complete loss of promoter
activity. When a four base substitution mutation was
introduced into the minimal functional promoter at the
binding site for lymphoid enhancer factor 1 (LEF-1),
promoter activity in transgenic mice was decreased but
specificity was not affected. To investigate the interaction
of trans-acting factors within the minimal K2.10 promoter
we performed DNase I footprinting analyses and
electrophoretic mobility shift assays. In addition to LEF-1,
Sp1, AP2-like and NF1-like proteins bound to the
promoter. The Sp1 and AP2-like proteins bound sequences
flanking the LEF-1 binding site whereas the NF1-like
proteins bound closer to the transcription start site. We
conclude that the LEF-1 binding site is an enhancer
element of the K2.10 promoter in the hair follicle cortex and
that factors other than LEF-1 regulate promoter tissue-
and differentiation-specificity.
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SUMMARYINTRODUCTION
The hair follicle is a specialised epithelial structure derived
from the epidermis. It is composed of several different cell
types which form the medulla, cortex and outer cuticle of the
hair shaft and the surrounding inner and outer root sheaths.
Differentiation of cells emerging from the follicle bulb to form
the hair involves the coordinated activation of many hair
structural genes (for review see Powell and Rogers, 1997). The
major proteins synthesised in the hair shaft are the keratin
intermediate filament (IF) and keratin-associated proteins
(KAP). Keratin IF are composed of type I and type II proteins
which are co-expressed in specific pairs to form 8-10 nm
diameter heteropolymeric filaments (Steinert and Roop, 1988).
At least four different pairs of hair keratin IF are expressed in
the follicle cortex and the genes are activated sequentially,
early in hair shaft formation (Kaytes et al., 1991; Powell et al.,
1992; Tobiasch et al., 1992; Winter et al., 1994; Rogers et al.,
1996, 1997). The focus of this study, the type II IF gene K2.10,
is first expressed in differentiating cortical keratinocytes of the
lower shaft (Powell et al., 1992). The KAP proteins which form
a matrix between the filaments comprise several families
whose genes are activated after the IF genes (for review see
Powell and Rogers, 1997).
The intricate pattern of hair keratin gene expression during
cortical cell differentiation suggests that the timing andlocation of transcriptional activation are precisely controlled.
Little is known about how this is achieved. Is there a follicle-
specific transcription factor which acts as a master switch for
all hair keratin genes, or does transcription of each gene occur
independently, utilising various combinations of widely
expressed factors? The latter scenario has been suggested for
regulation of several epidermal keratin IF genes (for review see
Eckert et al., 1997). Binding sites for AP1, AP2, Sp1, POU
factors and other common transcription factors, sometimes
found in clusters in regulatory elements, are important for
expression of many epidermal keratin IF genes.
Consensus AP1 and AP2 binding sites occur in the promoters
of several hair keratin genes and sequence comparisons have
identified other putative regulatory motifs (McNab et al., 1989;
Kaytes et al., 1991; Powell et al., 1991, 1992). One prominent
motif, originally termed HK-1 (Powell et al., 1991), is now
recognised as a binding site for lymphoid enhancer factor 1
(LEF-1) (Zhou et al., 1995). LEF-1 was first identified as a pre-
B and T cell protein with a DNA-binding domain homologous
to that of high mobility group proteins, and is related to T cell
factor 1 (TCF-1) (Travis et al., 1991; Waterman et al., 1991).
LEF-1/TCF-1 binding sites are found in a number of T cell-
specific enhancers, including those of the T cell receptor (TCR)-
a, -b and -d genes, the CD3, CD4 and adenosine deaminase
genes and HIV-1 (Gottschalk and Leiden, 1990; Redondo et al.,
1990; Sawada and Littman, 1991; Haynes et al., 1996). LEF-1
3488 S. M. Dunn and othershas an essential role in TCR-a and HIV-1 enhancer activation
in which it acts synergistically with other transcription factors
(Giese et al., 1995; Sheridan et al., 1995).
The perceived biological roles of LEF-1 expanded when it
was shown to be expressed widely during embryogenesis
(Oosterwegel et al., 1993). Functional studies using targeted
gene inactivation and ectopic expression indicate that LEF-1
plays an essential part in hair follicle morphogenesis (van
Genderen et al., 1994; Zhou et al., 1995; Kratochwil et al.,
1996). In mutant mice deficient in LEF-1, follicle development
is initiated at the normal stage but is arrested shortly thereafter
and the mice are hairless (van Genderen et al., 1994). During
follicle morphogenesis and hair growth, LEF-1 is expressed in
several locations, notably the embryonic ectoderm, the
ectodermal cells at the leading edge of the follicle placode, the
follicle bulb and lower shaft of adult follicles and the dermal
papilla (Zhou et al., 1995). The finding of conserved LEF-1
binding motifs in the promoters of many hair keratin genes
(Powell et al., 1991; Zhou et al., 1995; Rogers et al., 1996)
implies a central role for this factor in hair keratin gene
transcription in the terminal stages of hair growth.
To investigate promoter function of hair keratin genes it is
necessary to use transgenic mice because of the lack of a cell
culture system. Preliminary studies of two hair keratin
promoters have been undertaken in transgenic mice, the sheep
K2.10 promoter (Powell and Rogers, 1990; Keough et al.,
1995) and a mouse KAP gene promoter (McNab et al., 1990).
In both cases, transgene specificity mimicked that of the
endogenous gene.
We have shown previously that 2.8 kb of the sheep K2.10
promoter is sufficient to drive correct expression of the SV40
T antigen (TAg) in the follicle cortex of transgenic mice
(Keough et al., 1995). Here we have used mouse transgenesis
to test smaller fragments of the proximal promoter of the sheep
K2.10 gene for activity and we show that 400 bp of promoter
is able to function as a hair cortex-specific promoter. Using in
vitro techniques we show that transcription factors from the
Sp1, AP2 and NF1 families are capable of binding to this
promoter. LEF-1 also binds the K2.10 promoter and we show
that the 400 bp promoter is reduced in activity when the LEF-
1 binding site is mutated. We postulate that LEF-1 acts as a
general enhancer of K2.10 transcription, possibly by
coordinating interactions between flanking transcription
factors, thus adding a further dimension to the function of LEF-
1 in hair development.
MATERIALS AND METHODS
Construction of K2.10-lacZ fusion genes
The transgenes were generated from a K2.10 promoter construct
containing an engineered SalI site in the 5¢ untranslated region at
position +53 (Keough et al., 1995). The HindIII/BamHI lacZ fragment
(3.85 kb) from pCH110 (Pharmacia) was cloned into this site. The
K2.10(400)-lacZ transgene was isolated by ApaI digestion and
contained approximately 400 bp of K2.10 proximal promoter from
nucleotide - 350 to +53. K2.10(400D LEF-1)-lacZ was generated
by site-directed mutagenesis of the LEF-1 binding site at position
- 185 in K2.10(400)-lacZ using the oligonucleotide 5¢ -
TCAGGCCTGTTTCATCCTAGACGCCGTTTACGAGCTTC-3¢ . The
transgene fragment was isolated using ApaI as above. K2.10(400)-
lacZ and K2.10(400 D LEF-1)-lacZ contained approximately 200 bp ofK2.10 exon 1 sequence at the 3¢ end of the lacZ fragment. The
K2.10(200)-lacZ transgene contained 200 bp of K2.10 proximal
promoter from the HincII site at position - 149 to the SalI site at +53
but did not contain the K2.10 exon 1 sequence.
Production of transgenic mice and b -galactosidase
histochemistry
Transgenes were microinjected into fertilised mouse oocytes
essentially as described by Hogan et al. (1986) and transgenic mice
were detected by Southern blot analysis with a 3.85 kb lacZ probe.
Mouse dorsal skin containing hair follicles in anagen phase was
embedded in OCT compound. Cryostat sections (14 m m) were air-
dried and fixed in 0.2% glutaraldehyde for 2 minutes. b -Galactosidase
activity was detected by the conversion of 5-bromo-4-chloro-3-
indolyl-b -D-galactopyranoside (X-gal) to blue stain (Sanes et al.,
1986). Sections were counterstained with eosin and mounted in Gurr¢ s
Depex mounting medium.
Preparation of nuclear extracts
Hair (or wool) follicles were isolated from the skins of 10-15 two to
four day old Swiss mice (or from fetal sheep between days 100 and
140 of gestation) using trypsin and collagenase digestion (Rogers et
al., 1987). Extracts from sheep and mouse follicles produced the same
results in DNA binding experiments and were used interchangeably.
Washed, pelleted follicles were resuspended in 10 mM Hepes, pH 7.9,
10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM
PMSF, 0.6% NP40 and cells were lysed in a Dounce homogeniser.
Nuclei were pelleted, then extracted in 300-500 m l of 10 mM Hepes,
pH 7.9, 0.1 mM EDTA, 0.1 mM EGTA, 1.5 mM MgCl2, 400 mM
KCl, 25% (v/v) glycerol, 0.5 mM DTT, 0.5 mM PMSF and incubated
on ice for 20 minutes. Debris was pelleted by centrifugation for 10
minutes at 15,000 g at 4°C. The supernatant was collected and aliquots
of the nuclear extract were snap frozen and stored at - 70°C.
Recombinant human AP2 was purchased (Promega).
Electrophoretic mobility shift assay (EMSA)
Electrophoretic mobility shift assays (EMSA) were performed
essentially as described by Schneider et al. (1986). Binding reactions
contained 5-6 m g of follicle nuclear extract and 0.2 ng of 32P-labelled,
double-stranded oligonucleotide probe in a final volume of 15-20 m l,
which included 20 mM Tris-HCl, pH 8, 1 mM EDTA, 5 mM DTT,
50 mM KCl, 0.5 m g polydIdC (Boehringer Mannheim) and 10% (v/v)
glycerol. Unlabelled competitor DNA (at 100-fold molar excess over
probe) was added prior to probe addition where indicated. Reactions
were incubated at room temperature for 20 minutes. The K2.10
probe sequences are shown in Fig. 3 and the D LEF-1 probe 
was 5 ¢ -AACGGCGTCTAGGATGAAAC-3¢ . The non-specific
oligonucleotide was 5 ¢ -TGGCTCAGGAGGAAGATCCGC-3¢ . Probes
used as canonical binding sites for transcription factors were: Sp1
(Briggs et al., 1986) 5¢ -ATTCGATCGGGGCGGGGCGAGC-3¢ ; NF1
(Leegwater et al., 1985) 5¢ -TTTTGGATTGAAGCCAATATGATAA-
3¢ ; AP2 (Williams et al., 1988) 5 ¢ -GATCGAACTGACCG-
CCCGCGGCCCGT-3 ¢ . Where antibodies were included, 1 m l of
rabbit polyclonal antiserum was incubated with the mixture minus
probe for 30 minutes on ice, the probe was then added and incubation
continued for 20 minutes at room temperature. Antiserum against
CTF/NF1 proteins was a gift from Dr N. Tanese (New York University
Medical Center) and LEF-1 antiserum was a gift from Dr R.
Grosschedl (University of California, San Francisco). Affinity-
purified rabbit antibodies to Sp1 were purchased from Santa Cruz
Biotech. Reactions were electrophoresed at 150V on 6%
polyacrylamide gels buffered by 50 mM Tris HCl, pH 8.5, 380 mM
glycine, 2 mM EDTA and dried gels were autoradiographed for 12 to
72 hours.
DNase I footprinting
DNase I footprinting was performed with modifications of a described











xpression of sheep K2.10-lacZ constructs in transgenic mice. The 3.85
was cloned at position +53 (bent arrows indicate the transcription
 the 5 ¢ untranslated region of K2.10. The K2.10 sequence +53 to +271
ion of exon 1) was present at the 3 ¢ end of the lacZ insert in constructs
2.10(400D LEF-1)-lacZ. The K2.10 promoter sequences are stippled
wn at - 350 or - 149. The LEF-1 site at - 185, mutated in
cZ, is boxed and labelled D LEF-1. Diagram not drawn to scale. The
ice which express b -galactosidase is shown as a fraction of the total
ice for each construct.procedure (Jerkins et al., 1995). Probes of 150 to 300 bp were
generated by PCR using a plasmid template containing the K2.10
promoter. One PCR primer was end-labelled using [g -32P]ATP and T4
polynucleotide kinase. The same 32P-labelled primer was used in
dideoxynucleotide chain termination sequencing reactions, which
were electrophoresed in parallel with the footprint reactions to locate
footprint positions. DNA binding reactions containing 50 m g of crude
nuclear extract (or 30 ng of recombinant AP2 protein), 50 mM KCl,
20 mM Tris-HCl, pH 8, 1 mM EDTA, 1 mM DTT, 10% glycerol, 1.5
m g polydIdC and 2 ng of probe in a final volume of 50 m l were
incubated on ice for 10 minutes then at room temperature for a further
10 minutes. 50 m l of 5 mM CaCl2, 10 mM MgCl2 were added to the
mixture and incubation was continued for 5 minutes at room
temperature. DNase I (Worthington Biochemical Corporation) was
added to a concentration of between 0.2 and 2 units/ml and allowed
to digest for 30 seconds at room temperature. Digestion was stopped
by the addition of 90 m l of 30 mM EDTA, 200 mM NaCl, 1% SDS
and 100 m g/ml yeast RNA, samples were extracted with
phenol/chloroform, ethanol precipitated, then resuspended in
formamide load solution. DNA was separated on 6% polyacrylamide,
8 M urea sequencing gels, which were then dried and
autoradiographed.
RESULTS
Functional mapping of the K2.10 promoter
We have previously shown that 2.8 kb of sheep K2.10 5¢
promoter sequence directs expression to the hair follicle cortex
in transgenic mice (Powell and Rogers, 1990; Keough et al.,
1995). To further define the minimal functional K2.10
promoter, a K2.10(400)-lacZ transgene was constructed,
containing 400 bp of proximal K2.10 promoter (- 350 to +53)
linked to the E. coli lacZ reporter gene (Fig. 1). Twelve founder
(G0) transgenic mice were generated with between 1 and 200
copies of the transgene per genome (data not shown). Only four
mice expressed the transgene as determined by b -galactosidase
activity (Fig. 2A). Expression was confined to the cortex of the
hair follicle in each case and was usually seen over the entire
cortex, while no expression was detected elsewhere in the skin.
Transgene expression was not copy number-dependent, as the
greatest intensity of b -galactosidase staining was observed in
a mouse with a low transgene copy number, while some of the
non-expressing animals carried a large
number of transgenes (data not shown).
A second deletion construct,
K2.10(200)-lacZ, containing the
proximal 200 bp of the K2.10 promoter
(- 149 to +53) linked to lacZ (Fig. 1) was
then analysed. Seventeen G0
K2.10(200)-lacZ transgenic mice were
generated, with transgene copy numbers
ranging from 5 to 100 copies. No
b -galactosidase activity was detectable in
the hair follicles or skin of these mice
(data not shown), indicating that
sequences outside the 200 bp proximal
promoter are required for expression.
To investigate the role of the highly
conserved LEF-1 motif (HK-1: Powell et
al., 1991; Zhou et al., 1995), the
K2.10(400 D LEF-1)-lacZ construct (Fig.
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binding site at - 185 was mutated from 5¢ -CTTTGAAG-3 ¢ to
5¢ -CGTCTAGG-3¢ , a mutation which abolished protein
binding (see later, Fig. 4B). Thirteen G0 K2.10(400D LEF-1)-
lacZ transgenic mice were produced with copy numbers
ranging from approximately 10 to 100 copies. Two transgenic
mice showed a low level of b -galactosidase activity in the hair
follicle cortex (Fig. 2B,C). Unlike K2.10(400)-lacZ mice,
expression in the K2.10(400D LEF-1)-lacZ animals was patchy
and only a few cortical cells were stained. Additionally, both
mice showed expression in only 1-10% of pelage follicles.
Thus, mutation of the LEF-1 site appeared to reduce the level
of hair keratin gene expression, but did not affect cell type
specificity.
Nuclear proteins bind adjacent LEF-1 and AP2 sites
in the K2.10 promoter
Having ascertained that the K2.10 400 bp promoter contained
the sequence information required for follicle cortex-specific
expression, we attempted to identify nuclear proteins in the
follicle which specifically bound sequences within this
promoter. An impediment to studying hair keratin gene
regulation is the difficulty in preparing purified cell populations
which express the appropriate keratin genes. The whole follicle
nuclear extracts used here to analyse DNA-binding proteins
were crude preparations containing other follicle cell types in
addition to the cortical cells where K2.10 is expressed.
Nevertheless, the major part of the follicle preparation
consisted of hair cortex, as assessed microscopically (data not
shown). Overlapping probes covering the K2.10 promoter from
- 350 bp to the transcription start site (Fig. 3) were synthesised
for EMSA and DNase I footprinting assays. While many DNA-
protein interactions were detected throughout the promoter
(data not shown), we focussed our initial investigations on parts
of the promoter containing recognised sequence motifs.
Using a probe centred over the LEF-1 site, we observed a
DNase I footprint over the sequence - 193 to - 152 which spans
this motif (Fig. 4A). A 20 bp oligonucleotide probe (D)
containing the LEF-1 site bound proteins from follicle nuclear
extracts to form a doublet complex in EMSA (Fig. 4B).
Specificity of this complex was demonstrated by the ability of
3490 S. M. Dunn and othersa 100-fold molar excess of unlabelled oligonucleotide D, but
not a non-specific sequence, to compete for binding to the
probe. There was no detectable binding to the oligonucleotide
D LEF-1 which carried the same mutated bases as used in the
K2.10(400D LEF-1)-lacZ transgene (Fig. 4B; see Materials and
Methods). Evidence for involvement of LEF-1 in the complex
binding oligonucleotide D was obtained by showing that LEF-
1 antiserum ablated binding of the slower migrating component
of the complex, but antibodies to CTF/NF1 transcription
factors or an equivalent amount of non-specific protein (BSA)
had no effect on complex formation (Fig. 4B). The
unidentified, faster migrating component, while specific forFig. 2. Expression of K2.10-lacZ constructs in the skin of transgenic
mice. (A) Skin from a K2.10(400)-lacZ transgenic mouse. Specific b -
galactosidase activity (blue staining) is localised to the cortex of the
hair follicle, as seen in the follicles where the bulb and lower shaft
are visible and the K2.10 promoter activity has just commenced
(arrowheads). Staining beyond the cortex further along the shaft is
due to diffusion of the reaction product. (B,C) Examples of patchy
expression of b -galactosidase in the follicle cortex (arrowheads) in
skin from two independent K2.10(400D LEF-1)-lacZ transgenic mice.
No expression is observed in the epidermis for either construct. Bars,
100 m m.probe D, did not appear to interact with the antiserum as it was
neither reduced in intensity nor supershifted. Interestingly, this
component was competed by oligonucleotide E (Fig. 4B).
Several nucleotides downstream of the LEF-1 binding site is
the sequence 5 ¢ -GCCTGAGGC-3¢ which resembles an AP2
binding site (Williams et al., 1988). Oligonucleotide E which
spans this site bound a protein(s) from follicle nuclear extracts
to form a complex of low mobility which was competed by
unlabelled ‘self’ oligonucleotide and an AP2 consensus
oligonucleotide but not by oligonucleotide D or a non-specific
competitor (Fig. 4C). Probe E also formed a second specific
complex, which was not competed by the consensus AP2
binding site but was weakly competed for by oligonucleotide
D (Fig. 4C).
The DNase I footprint produced by follicle nuclear extract
which spanned the LEF-1 binding site also encompassed the
putative AP2 binding site in K2.10. In addition, recombinant
AP2 protein produced a specific footprint over this AP2 motif
(- 183 to - 152; Fig. 4A). The footprinted sequences spanning
the LEF-1 and AP2 sites all lie outside the promoter fragment
used in the K2.10(200)-lacZ construct which had no activity in
transgenic mice.
Multiple sites upstream of the LEF-1 site bind Sp1
Follicle nuclear extracts produced DNase I footprints at - 343
to - 318 and at - 216 to - 206 of the 400 bp K2.10 promoter
(data not shown). We identified two sequences overlapping
these footprinted regions which matched the consensus binding
site for Sp1 (Fig. 5A; Wu et al., 1994). These potential Sp1
binding sites were tested for binding of proteins by EMSA.
Binding to probes A and C resulted in two retarded bands
which were competed with a 100-fold molar excess of an Sp1
consensus oligonucleotide, indicating involvement of the Sp1
transcription factor (Fig. 5B). Further evidence of Sp1 binding
to oligonucleotides A and C was obtained when a supershifted
complex was produced by Sp1 antibody. The uppermost ‘Sp1’
band for both probes was the most affected by the Sp1
antiserum. A control antiserum, directed to CTF/NF1 proteins,
produced a weak supershift of a complex binding to probe A
but not probe C (Fig. 5B). Probes A and C also bound several
other proteins, unique to each probe. For both probes, there
were at least four bands which competed specifically with the
unlabelled probe oligonucleotide but not with the Sp1
consensus sequence. None of these complexes has been
identified as yet.
Another Sp1 consensus sequence is located upstream at -
240 to - 231 (Figs 3, 5A). For reasons unknown, DNase I
footprinting assays did not give reproducible results over this
region. However, oligonucleotide probe B that spans this
sequence produced two major (a and b) and two minor
complexes (labelled Sp1; Fig. 5C). An Sp1 consensus
oligonucleotide specifically competed for the two minor
complexes. To substantiate the Sp1 interaction, when the bases
GGA in the Sp1-like motif of oligonucleotide B were mutated
to TAC (the two Gs are invariant in the Sp1 consensus; see Fig.
5A) there was a specific loss of both minor bands (Fig. 5C).
The identity of the two major complexes (a and b) which were
competed by unlabelled oligonucleotide B but not by the Sp1
consensus oligonucleotide is not known.
An interesting result was obtained when the overlapping
oligonucleotide C was used as an unlabelled competitor for

































Fig. 3. Nucleotide sequence of the 5 ¢
proximal domain of the sheep K2.10
gene from - 350 to +53 in the 5¢
untranslated region. The arrowheads
indicate the 5¢ ends of the K2.10(400)
and K2.10(200) promoter deletions
shown in Fig. 1. The bent arrow at +1
denotes the transcription initiation site.
Sequences of oligonucleotides A-G
used in EMSA are underlined. The
four bases mutated in the
oligonucleotide D sequence to make
the oligonucleotide D LEF-1 (see
Materials and Methods) are indicated
by asterisks. Putative transcription
factor binding sites and a TATA motif
are boxed.proteins binding probe B, in which a complex running as a
smear on the gel was noted in place of the Sp1-like complex
(Fig. 5C). The same effect was not seen using the Sp1
consensus oligonucleotide as a competitor. This is suggestive
of a specific association between proteins binding to probe B
and proteins binding to oligonucleotide C.
Interaction of NF1-like factors with the proximal
region of the K2.10 promoter
Three potential binding sites for NF1 transcription factors were
detected in the proximal region of the K2.10 promoter between
- 121 and - 87. Each of these sequences (boxed in Fig. 3)
matched only one half of the palindromic NF1 consensus
binding site (5 ¢ -TTGGC(N)5GCCAA-3¢ ; Chaudhry et al.,
1997), but such ‘half-sites’ have been shown to bind NF1,
albeit with low affinity (O’Connor and Bernard, 1995).
Sequences overlapping the NF1 motifs at - 125 to - 109 and
- 105 to - 87 were protected from digestion in the DNase I
footprinting assay using follicle nuclear proteins (Fig. 6A).
Oligonucleotides F and G, which span these footprinted
sequences, were used as probes in EMSA and a major complex
formed using either probe (Fig. 6B). This complex contained
a protein(s) antigenically related to NF1 as it was supershifted
by NF1 antiserum. The consensus NF1 oligonucleotide also
competed efficiently for the complex bound to probe G (Fig.
6B, lane 10) and probe F (data not shown). Oligonucleotide F
appeared to have a lower affinity for the NF1-like protein(s)
than probe G did, as indicated by competition experiments
(Fig. 6B, lanes 8 and 9).
DISCUSSION
Expression of K2.10-lacZ transgene constructs
Transgenic mice carrying either a 14.5 kb sheep K2.10
transgene or a fusion gene containing 2.8 kb of 5¢ promoter
sequence express transgene activity in the mouse hair follicle
cortex according to the pattern of the endogenous gene in sheep
(Powell and Rogers, 1990; Keough et al., 1995). In the present
study, shortening the promoter to 400 bp of 5 ¢ proximal
sequence produced a similar expression pattern where b -galactosidase expression was confined to the follicle cortex of
transgenic mice. Thus, as little as 400 bp of K2.10 promoter
sequence contains the regulatory elements required for K2.10
expression in the follicle cortex. However, when the promoter
was further deleted to 200 bp no expression was detectable in
transgenic mice.
The lack of expression from the K2.10(200)-lacZ transgene
could be explained by a number of possibilities. Although the
X-gal staining procedure is very sensitive, there is a threshold
of enzyme concentration below which no blue staining is seen
(Fire, 1992). Very low levels of expression from the minimal
promoter may therefore go undetected. A second possibility is
the presence of a negative regulatory element within this region
of the promoter whose potential effects in the complete
promoter may be over-ridden by upstream enhancers. NF1
proteins have been shown to act as repressors of some
promoters where they bind to negative regulatory elements
(Roy et al., 1992; Adams et al., 1995; Jahroudi et al., 1996),
and we have demonstrated binding of NF1-like proteins to
sequences within the 200 bp promoter. It should also be noted
that the K2.10(200)-lacZ construct lacks 200 bp of K2.10 exon
1 sequence that was present in all other K2.10 transgenes.
Sequence analysis of this region reveals the presence of
possible AP2 and Sp1 binding sites (data not shown). However,
it is not known whether these motifs are functionally
significant or simply reflect the GC-rich nature of the sequence
which is typical of eukaryotic gene coding regions.
Reduction of the K2.10 promoter from 2.8 kb to 400 bp
resulted in progressively fewer expressing transgenic mice.
The large K2.10 transgene (14.5 kb with 2.8 kb of 5 ¢ promoter;
Powell and Rogers, 1990) was active in virtually all transgenic
mice albeit not in a copy-dependent manner (B. Powell,
unpublished data). Similarly, in the production of keratin
transgenic sheep, the larger K2.10 promoter was active in most
transgenic sheep (Bawden et al., 1998). It should be noted,
though, that the 14.5 kb transgene and the transgenes used in
sheep also contained 5 kb of 3¢ flanking sequence from the
K2.10 gene, which may also help regulate expression. The
K2.10-TAg construct with 2.8 kb of K2.10 promoter was active
in ten out of twenty transgenic mice (Keough et al., 1995),
whilst K2.10(400)-lacZ was expressed in only four of twelve






Dmice. The reduction in the percentage of transgenic mice
expressing K2.10-lacZ as the promoter fragment was shortened
may indicate that shorter promoters are more susceptible to
‘position effects’ in the genome, possibly due to the loss of
isolating elements such as matrix attachment or locus control
regions (Phi-Van et al., 1990; Dillon and Grosveld, 1993) or
distal enhancer elements (Walters et al., 1996).
Mutation of the LEF-1 binding site reduces K2.10
transgene activity
The transcription factor LEF-1 is understood to play an
architectural role in some T cell enhancers by inducing a sharp
bend in the DNA upon binding (Grosschedl et al., 1994). This
is thought to bring together factors binding to other sites in the
promoter to form a higher-order nucleoprotein complex which
activates transcription.
We tested the function of the LEF-1 sequence in the 400 bp
K2.10 promoter by mutating it such that LEF-1 could no longer
bind. In the K2.10(400D LEF-1)-lacZ transgenic mice,
transgene expression in the hair follicle cortex was preserved
but the expression level was significantly reduced. Therefore,
it appears unlikely that LEF-1 is responsible for the follicle-
specificity of K2.10 expression, but it may augment
transcription levels.
The reduction in K2.10 promoter activity in
K2.10(400D LEF-1)-lacZ transgenic mice is, to our knowledge,
the first evidence which directly shows that the LEF-1 binding
site is functionally significant in the transcriptional regulation
of a hair keratin gene. As Zhou et al. (1995) suggested, LEF-
1 expression in the hair follicle may play a role in facilitating
expression of a large set of hair keratin genes. This is
strengthened by the presence of LEF-1 sites in the proximal
promoters of 13 hair keratin promoters and by the localisation
of expression of LEF-1 in the follicle bulb region where
cortical cells originate.Fig. 4. LEF-1 and AP2-like factors bind the sheep K2.10 promoter.
(A) DNase I footprint analysis of a 155 bp K2.10 promoter fragment
( - 199 to - 130 shown here). The fragment was 32P-end-labelled on
the upper strand and incubated with no protein (lane 1), 30 ng of
recombinant human AP2 (lane 2) or 50 m g of crude follicle nuclear
extract (lane 3). Positions of the consensus LEF-1 and AP2 sites are
indicated diagrammatically. Filled arrows and arrowhead show
footprint boundaries and hypersensitive sites for AP2; open arrows
show footprint boundaries for follicle nuclear extract. (B) EMSA
analysis of complexes formed with follicle nuclear extract and 32P-
labelled, double-stranded oligonucleotides. Probe D LEF-1 (D ) was
used in lane 5 and no binding was detected. Probe D (encompassing
the LEF-1 site) was used in lanes 1-4, 6-8. The doublet complex
formed is indicated by dashes. Competitor oligonucleotides at 100-
fold molar excess are: lane 1, none; lane 2, non-specific (NS); lane 3,
oligo D; lane 4, oligo E. The lower band is competed specifically
with oligo E (diamond). Reactions incubated in the presence of
antibodies are shown in lane 6 (LEF-1 antiserum; asterisk denotes
loss of band) and lane 7 (CTF/NF1 antiserum) and lane 8 contained
BSA protein. Unbound probe, P. (C) EMSA analysis of follicle
nuclear extract interacting with probe E encompassing the AP2 site
(free probe is not shown). The uppermost complex (competed with
AP2 oligo: lane 3) is labelled AP2 and the lower complex is marked
by an arrowhead. Lane 1, no competitor; lanes 2-5 contain 100-fold
molar excess of competitor as follows: lane 2, oligo E; lane 3, AP2
consensus oligo; lane 4, oligo D; lane 5, non-specific.
Analysis of LEF-1 and other factor binding sites in
the K2.10(400) promoter
When the LEF-1 site in the K2.10 promoter was analysed by
EMSA a doublet complex was noted. One band appeared to be
the result of LEF-1 binding as it was blocked by LEF-1-specific
antibodies. The faster migrating band was not recognised by
LEF-1 antibodies and possibly contained degraded protein or
a LEF-1 variant, which shared binding site specificity but not
identical antigenic determinants. Hence, while we have shown
that the LEF-1 binding element is functionally important in the
K2.10 400 bp promoter we cannot discriminate between the
contribution of LEF-1 and the other protein.3493Hair keratin transcriptional regulation
Studies on the TCR- a and HIV-1 enhancers have shown that
LEF-1 alone cannot activate transcription and that interaction
with other transcription factors bound to flanking sites in the
enhancer is required (Giese and Grosschedl, 1993; Sheridan et
al., 1995; Giese et al., 1995). We have tested follicle nuclear
extracts for other proteins that bind sequences flanking the
LEF-1 motif in the K2.10 400 bp promoter and which, by
analogy, may be part of an activation complex involving LEF-
1. A potential AP2 binding site downstream of the LEF-1 motif
was shown to bind protein by EMSA and DNase I footprint
analysis. It is not surprising that AP2 might regulate hair
keratin genes as functional AP2 binding sites are found in
several epidermal keratin IF promoters (Leask et al., 1991;
Ohtsuki et al., 1993; Eckert et al., 1997). The EMSA probe
spanning the K2.10 AP2 binding site also formed a complex
involving protein(s) distinct from AP2. There may be similarity
between the proteins in this second complex and the LEF-1
binding site complex as indicated by cross-competitions in
EMSA. Notably, the unidentified AP2 site complex was
reduced in the presence of the LEF-1 oligonucleotide while the
AP2 site oligonucleotide competed for the faster migrating
band formed by the LEF-1 probe.
Three distinct regions of the K2.10 400 bp promoter
upstream of the LEF-1 site bound a complex which, by several
lines of evidence, was likely to include the transcription factor
Sp1. Sp1 may be a major contributor to the level of expression
achieved by the K2.10 400 bp promoter, even though the
individual sites do not appear to be high affinity sites for Sp1,
because interactions between multiple Sp1 factors bound at
different DNA sites can result in synergistic effects (Pascal and
Tjian, 1991; Persengiev et al., 1995). The novel complexFig. 5. Characterisation of Sp1 binding sites in the K2.10 promoter.
(A) Sequence comparisons of the Sp1 consensus binding site (Wu et
al., 1994) and three sequences in the K2.10 promoter, identified by
the oligonucleotide in which they are located (see Fig. 3). The ( - )
and (+) indicate lower and upper strand sequences, respectively.
Bases underlined differ from the Sp1 consensus. The bases GGA in
bold-type in sequence B are mutated to TAC in the oligonucleotide
B-mut. (B) EMSA analysis using oligonucleotides A (lanes 1-6) and
C (lanes 7-12) as probes. Reactions shown in lanes 1 and 7 contained
no competitors. Competitor oligonucleotides used at 100-fold molar
excess over probe are: lanes 2 and 8, non-specific; lane 3, oligo A;
lane 9, oligo C; lanes 4 and 10, Sp1 consensus oligo. The bands
labelled Sp1 are specifically competed for by the Sp1 consensus
oligonucleotide. The complexes marked by arrows bind specifically
to probe A and those marked by arrowheads bind specifically to
probe C, as they are competed by ‘self’ oligonucleotide but not by
non-specific or Sp1 consensus oligonucleotides. Antiserum to
CTF/NF1 proteins was included in reactions shown in lanes 5 and
11, and a weak supershift in lane 5 is indicated (diamond). Reactions
incubated in the presence of Sp1 antibodies are shown in lanes 6 and
12 and supershifts are denoted by asterisks. (C) EMSAs performed
with oligonucleotide B (lanes 1, 3-8) and B-mut (lane 2) as probes.
Lanes 1-4 are over-exposed to highlight the ‘Sp1’ complexes. All
marked complexes are competed by excess unlabelled
oligonucleotide B (lane 4) but not by a non-specific oligonucleotide
(lanes 3 and 7) (unmarked complexes in lanes 1-4 are non-specific).
Lanes 1, 2 and 5 contain no competitor. Lane 8 shows competition of
the two slowest migrating bands by the Sp1 consensus
oligonucleotide. Addition of competitor oligonucleotide C (lane 6)
results in a novel complex migrating ahead of the ‘Sp1’ bands as a
smear (bracket). Unbound probe, P.
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Fig. 6. K2.10 sequences containing multiple NF1 binding sites are
bound by follicle nuclear proteins. (A) DNase I footprinting
performed on a 155 bp K2.10 promoter fragment ( - 132 to - 65
shown here) 32P-end-labelled on the upper strand. The positions of
three NF1 half-sites (5¢ -TTGGC-3 ¢ ) are boxed at the left of the
figure. The probe was incubated with no protein (lane 1) or 50 m g of
follicle nuclear extract (lane 2). Protected regions are bracketed and a
DNase I hypersensitive site is indicated by an arrowhead. (B) EMSA
analysis of proteins interacting with oligonucleotide probes F (lanes
1-3) and G (lanes 4-10) (free probe is not shown). The major
complex is marked as NF1. Unmarked bands are non-specific.
Antiserum to CTF/NF1 proteins was included in reactions shown in
lanes 2 and 5 and a supershifted complex (asterisk) is seen for each
probe, accompanied by a decrease in the NF1 complex. Lanes 3 and
6 show reactions incubated in the presence of a control antiserum
(NS). For lanes 7-10, competitor oligonucleotides were added as
follows: lane 7, none; lane 8, oligo F; lane 9, oligo G; lane 10, NF1
consensus oligonucleotide.produced when one Sp1 site (oligonucleotide C) was added as
a competitor for binding of proteins to another (probe B) may
be due to interactions between Sp1 (or other) proteins bound
to both oligonucleotides. In addition to Sp1, we detected
several other proteins binding to all three probes containing
Sp1 sites. The same complexes were not formed with each
probe, reflecting the different sequences flanking the Sp1 core
motifs. These complexes are yet to be identified, although anNF1-like protein may bind near the upstream Sp1 site (probe
A) given some evidence of a supershifted complex with an
antiserum to CTF/NF1 proteins.
Like the LEF-1 and AP2 sites, the sequences which bound
Sp1 are in the distal part of the K2.10 400 bp promoter, which
was required for promoter activity in transgenic mice. In the
shorter 200 bp promoter, which contains a TATA box and the
transcription initiation site, we also discovered binding sites for
NF1-like proteins. As for Sp1 and AP2 transcription factors,
NF1-like factors have a widespread distribution and expression
of all four known isoforms of NF1 has been noted in mouse
whisker follicles (Chaudhry et al., 1997). While the 200 bp
promoter did not have any detectable activity in transgenic
mice, the NF1 sites may nevertheless be functional in the
context of the 400 bp promoter where proteins binding both
the proximal and distal regions of the promoter might act
synergistically on the basal transcription unit. Alternatively, it
is possible that NF1-like factors act in a negative way on the
basal K2.10 promoter, suppressing expression in the
proliferating follicle bulb cells, for example, or in other
noncortical cells. Cell-type-specific gene regulation involving
an NF1-like repressor has previously been reported for the rat
growth hormone promoter in nonpituitary cells (Roy et al.,
1992).
The transcription factors so far identified in this and other
studies of keratin gene expression (AP1, AP2, NF1 and Sp1)
are largely ones that are shared in the control of many other
genes. LEF-1, with its binding site positioned centrally in the
K2.10 minimal promoter and with its DNA bending properties,
may act as an enhancer of K2.10 expression by bringing
together such factors into an active complex. Other binding
proteins discovered in this study may also be involved in
defining tissue- and differentiation-specificity of hair keratin
gene expression. The data presented here define a minimal,
functional hair keratin promoter and provide a preliminary
characterisation of transcription factors which may be involved
in expression of the intermediate filament gene, K2.10, and
most likely other hair keratin genes.
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